Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study.

Rheumatol Ther · 2019 · PMC6393270 · PMID 30632015

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

At 12 months, an improvement of initial DAS28-ESR category or maintenance in DAS28-ESR remission/LDA was shown in 181 patients (61.4%, 95% CI [55.5–66.9%]) of the main population with a favorable trend observed in switch patients compared to no-switch patients (69.2%, 95% CI [58.7–78.5%] vs. 57.8%, 95% CI [50.8–64.7%]) (Table 3 ).

also in 1,335 other papers

a slight trendno p-value reported

In our study, although there was no statistically significant difference between the two groups in terms of therapeutic maintenance, a slight trend in favor to no-switch patients was observed.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.